Ferraris Warns of Cancelled Trials

Ferraris, the medical devicemaker, warned a number of cancelled trials from pharmaceutical companies will hit first half results. A number of pharmaceutical giants are also reviewing their projected spending on clinical trials, said the group, bringing the clinical trials division significantly below budget and taking full year figures below market expectations.

ShareCast (http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=430892)